Dow Up0.54% Nasdaq Up0.66%

Endocyte, Inc. (ECYT)

-NasdaqGS

15.80 Up 0.98(6.61%) 12:01PM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 34,682   191   -  
Cost of Revenue -   -   -  
Gross Profit 34,682   191   -  
Operating Expenses
Research Development35,670  28,828  14,561  
Selling General and Administrative15,054  10,000  6,039  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (16,043) (38,637) (20,600)
Income from Continuing Operations
Total Other Income/Expenses Net(620)93  1,572  
Earnings Before Interest And Taxes(16,663)(38,544)(19,028)
Interest Expense629  1,988  1,065  
Income Before Tax(17,292)(40,532)(20,093)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(17,292)(40,532)(20,093)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (17,292) (40,532) (20,093)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (17,292) (40,532) (20,093)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.